Glenmede Trust CO Na Nevro Corp Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $5,526 - $7,373	-40 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $78,438 - $116,152	-1,275 Reduced 96.96%	40 $3,000
Q2 2019 Aug 13, 2019	BUY	$58.04 - $66.99 $15,961 - $18,422	275 Added 26.44%	1,315 $85,000
Q1 2019 May 14, 2019	BUY	$35.52 - $62.62 $35,520 - $62,620	1,000 Added 2500.0%	1,040 $65,000
Q2 2018 Aug 15, 2018	SELL	$72.38 - $92.5 $246,598 - $315,147	-3,407 Reduced 98.84%	40 $3,000
Q4 2017 Feb 15, 2018	BUY	$65.94 - $93.31 $227,295 - $321,639	3,447	3,447 $237,000

150

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.